日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Telomere Length, Oxidative Stress, and Kidney Damage Biomarkers in Fabry Nephropathy

法布里肾病中的端粒长度、氧化应激和肾损伤生物标志物

Levstek, Tina; Bahčič, Erazem; Vujkovac, Bojan; Cokan Vujkovac, Andreja; Tesovnik, Tine; Remec, Žiga Iztok; Čuk, Vanja; Trebušak Podkrajšek, Katarina

Transcriptomic Approach in Understanding Fabry Nephropathy: A Review of the Literature and Proof-of-Concept

转录组学方法在理解法布里肾病中的应用:文献综述和概念验证

Breznik, Nika; Levstek, Tina; Vujkovac, Bojan; Cokan Vujkovac, Andreja; Trebušak Podkrajšek, Katarina

Dynamics of Leukocyte Telomere Length in Patients with Fabry Disease

法布里病患者白细胞端粒长度的动态变化

Levstek, Tina; Breznik, Nika; Vujkovac, Bojan; Nowak, Albina; Trebušak Podkrajšek, Katarina

Head-to-head trial of pegunigalsidase alfa versus agalsidase beta in patients with Fabry disease and deteriorating renal function: results from the 2-year randomised phase III BALANCE study

在患有法布里病且肾功能恶化的患者中,培尼加糖酶α与阿加糖酶β的头对头试验:来自为期2年的随机III期BALANCE研究的结果

Wallace, Eric L; Goker-Alpan, Ozlem; Wilcox, William R; Holida, Myrl; Bernat, John; Longo, Nicola; Linhart, Aleš; Hughes, Derralynn A; Hopkin, Robert J; Tøndel, Camilla; Langeveld, Mirjam; Giraldo, Pilar; Pisani, Antonio; Germain, Dominique Paul; Mehta, Ankit; Deegan, Patrick B; Molnar, Maria Judit; Ortiz, Damara; Jovanovic, Ana; Muriello, Michael; Barshop, Bruce A; Kimonis, Virginia; Vujkovac, Bojan; Nowak, Albina; Geberhiwot, Tarekegn; Kantola, Ilkka; Knoll, Jasmine; Waldek, Stephen; Nedd, Khan; Karaa, Amel; Brill-Almon, Einat; Alon, Sari; Chertkoff, Raul; Rocco, Rossana; Sakov, Anat; Warnock, David G

Safety and efficacy of pegunigalsidase alfa in patients with Fabry disease who were previously treated with agalsidase alfa: results from BRIDGE, a phase 3 open-label study

一项 BRIDGE 3 期开放标签研究的结果显示,在既往接受过阿加糖酶 alfa 治疗的法布里病患者中,培尼加糖酶 alfa 的安全性和有效性

Linhart, Aleš; Dostálová, Gabriela; Nicholls, Kathy; West, Michael L; Tøndel, Camilla; Jovanovic, Ana; Giraldo, Pilar; Vujkovac, Bojan; Geberhiwot, Tarekegn; Brill-Almon, Einat; Alon, Sari; Chertkoff, Raul; Rocco, Rossana; Hughes, Derralynn

Urinary-derived extracellular vesicles reveal a distinct microRNA signature associated with the development and progression of Fabry nephropathy

尿液来源的细胞外囊泡揭示了一种独特的microRNA特征,该特征与法布里肾病的发生发展相关。

Levstek, Tina; Vujkovac, Bojan; Cokan Vujkovac, Andreja; Trebušak Podkrajšek, Katarina

Do clinical guidelines facilitate or impede drivers of treatment in Fabry disease?

临床指南是促进还是阻碍了法布里病治疗的驱动因素?

Hughes, Derralynn A; Aguiar, Patrício; Lidove, Olivier; Nicholls, Kathleen; Nowak, Albina; Thomas, Mark; Torra, Roser; Vujkovac, Bojan; West, Michael L; Feriozzi, Sandro

Podocyturia in Fabry disease: a 10-year follow-up

法布里病中的足细胞尿:10 年随访

Bojan Vujkovac, Irena Srebotnik Kirbiš, Tajda Keber, Andreja Cokan Vujkovac, Martin Tretjak, Sandra Radoš Krnel

Urinary Extracellular Vesicles and Their miRNA Cargo in Patients with Fabry Nephropathy

法布里肾病患者尿液细胞外囊泡及其miRNA载荷

Levstek, Tina; Mlinšek, Teo; Holcar, Marija; Goričar, Katja; Lenassi, Metka; Dolžan, Vita; Vujkovac, Bojan; Trebušak Podkrajšek, Katarina

Cardiomyopathy and kidney function in agalsidase beta-treated female Fabry patients: a pre-treatment vs. post-treatment analysis

阿加糖酶β治疗的女性法布里病患者的心肌病和肾功能:治疗前与治疗后的分析

Wanner, Christoph; Feldt-Rasmussen, Ulla; Jovanovic, Ana; Linhart, Aleš; Yang, Meng; Ponce, Elvira; Brand, Eva; Germain, Dominique P; Hughes, Derralynn A; Jefferies, John L; Martins, Ana Maria; Nowak, Albina; Vujkovac, Bojan; Weidemann, Frank; West, Michael L; Ortiz, Alberto